Engulfment adaptor phosphotyrosine-binding-domain-containing 1 (GULP1) is a nucleocytoplasmic shuttling protein and is transactivationally active together with low-density lipoprotein receptor-related protein 1 (LRP1)

Biochemical Journal

Volumn 450, Issue 2, 2013, Pages 333-343

  Wahler, Anke ^a   Beyer, Anja Silke ^a   Keller, Ilona E ^a   Schnack, Cathrin ^a   Von Einem, Bjorn ^a   Propper, Christian ^a   Boeckers, Tobias M ^a   Peltan, Ithan D ^b   Strickland, Dudley K ^c   Hyman, Bradley T ^b   Von Arnim, Christine A F ^a  

^a UNIVERSITY OF ULM   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Adaptor protein; Alzheimer's disease; Amyloid precursor protein; Engulfment adaptor phosphotyrosine bindingdomain containing 1 (GULP1); Transactivation

Indexed keywords

ENGULFMENT ADAPTOR PHOSPHOTYROSINE BINDING DOMAIN CONTAINING 1 PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; NUCLEOCYTOPLASMIC TRANSPORT PROTEIN; PROTEIN FE65; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; BINDING SITES; CELL NUCLEUS; CYTOPLASM; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-1; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION;

EID: 84874066848     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20121100     Document Type: Article

References (39)

1. Selkoe, D. J. (2001) Alzheimer's disease: genes, proteins, and therapy. Phys. Rev. 81, 741-766
2. Hyman, B. T., Strickland, D. and Rebeck, G. W. (2000) Role of the low-density lipoprotein receptor-related protein in amyloid metabolism and Alzheimer disease. Arch. Neurol. 57, 646-650
3. McLoughlin, D. M. and Miller, C. C. (2008) The FE65 proteins and Alzheimer's disease. J. Neurosci. Res. 86, 744-754
4. Pietrzik, C. U., Yoon, I. S., Jaeger, S., Busse, T., Weggen, S. and Koo, E. H. (2004) FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein. J. Neurosci. 24, 4259-4265
5. Jacobsen, K. T. and Iverfeldt, K. (2009) Amyloid precursor protein and its homologues: a family of proteolysis-dependent receptors. Cell. Mol. Life Sci. 66, 2299-2318
6. Cao, X. and Sudhof, T. C. (2001) A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293, 1436-1436
7. Herz, J. and Strickland, D. K. (2001) LRP: a multifunctional scavenger and signaling receptor. J. Clin. Invest. 108, 779-784
8. Li, Y., Cam, J. and Bu, G. (2001) Low-density lipoprotein receptor family: endocytosis and signal transduction. Mol. Neurobiol. 23, 53-67
9. Kounnas, M. Z., Moir, R. D., Rebeck, G. W., Bush, A. I., Argraves, W. S., Tanzi, R. E., Hyman, B. T. and Strickland, D. K. (1995) LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted amyloid precursor protein and mediates its degradation. Cell 82, 331-340
10. May, P., Reddy, Y. K. and Herz, J. (2002) Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. J. Biol. Chem. 277, 18736-18743
11. Kinoshita, A., Shah, T., Tangredi, M. M., Strickland, D. K. and Hyman, B. T. (2003) The intracellular domain of the low density lipoprotein receptor-related protein modulates transactivation mediated by amyloid precursor protein and Fe65. J. Biol. Chem. 278, 41182-41188
12. Zurhove, K., Nakajima, C., Herz, J., Bock, H. H. and May, P. (2008) Secretase limits the inflammatory response through the processing of LRP1. Science Signaling 1, ra15
13. Uhlik, M. T., Temple, B., Bencharit, S., Kimple, A. J., Siderovski, D. P. and Johnson, G. L. (2005) Structural and evolutionary division of phosphotyrosine binding (PTB) domains. J. Mol. Biol. 345, 1-20
14. Borg, J. P., Ooi, J., Levy, E. and Margolis, B. (1996) The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol. Cell. Biol. 16, 6229-6241
15. Trommsdorff, M., Borg, J. P., Margolis, B. and Herz, J. (1998) Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J. Biol. Chem. 273, 33556-33560
16. Beyer, A. S., von Einem, B., Schwanzar, D., Keller, I. E., Hellrung, A., Thal, D. R., Ingelsson, M., Makarova, A., Deng, M., Chhabra, E. S. et al. (2012) Engulfment adapter PTB domain containing 1 interacts with and affects processing of the amyloid-precursor protein. Neurobiol. Aging 33, 732-743
17. Hao, Y., Perkinton, M. S., Chan, W. W., Chan, H. Y., Miller, C. C. and Lau, K. F. (2011) GULP1 is a novel APP-interacting protein that alters APP processing. Biochem. J. 436, 631-639
18. Su, H. P., Nakada-Tsukui, K., Tosello-Trampont, A. C., Li, Y., Bu, G., Henson, P. M. and Ravichandran, K. S. (2002) Interaction of CED-6/GULP, an adapter protein involved in engulfment of apoptotic cells with CED-1 and CD91/low density lipoprotein receptor-related protein (LRP). J. Biol. Chem. 277, 11772-11779
19. Gardai, S. J., McPhillips, K. A., Frasch, S. C., Janssen, W. J., Starefeldt, A., Murphy-Ullrich, J. E., Bratton, D. L., Oldenborg, P. A., Michalak, M. and Henson, P. M. (2005) Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123, 321-334
20. Elliott, M. R. and Ravichandran, K. S. (2010) Clearance of apoptotic cells: implications in health and disease. J. Cell Biol. 189, 1059-1070
21. von Arnim, C. A., Kinoshita, A., Peltan, I. D., Tangredi, M. M., Herl, L., Lee, B. M., Spoelgen, R., Hshieh, T. T., Ranganathan, S., Battey, F. D. et al. (2005) The low density lipoprotein receptor-related protein (LRP) is a novel secretase (BACE1) substrate. J. Biol. Chem. 280, 17777-17785
22. Minopoli, G., de Candia, P., Bonetti, A., Faraonio, R., Zambrano, N. and Russo, T. (2001) The amyloid precursor protein functions as a cytosolic anchoring site that prevents Fe65 nuclear translocation. J. Biol. Chem. 276, 6545-6550
23. Lee, E. J., Chun, J., Hyun, S., Ahn, H. R., Jeong, J. M., Hong, S. K., Hong, J. T., Chang, I. K., Jeon, H. Y., Han, Y. S. et al. (2008) Regulation Fe65 localization to the nucleus by SGK1 phosphorylation of its Ser566 residue. BMB Rep. 41, 41-47
24. von Rotz, R. C., Kohli, B. M., Bosset, J., Meier, M., Suzuki, T., Nitsch, R. M. and Konietzko, U. (2004) The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J. Cell Sci. 117, 4435-4448
25. Sadowski, I., Ma, J., Triezenberg, S. and Ptashne, M. (1988) GAL4-VP16 is an unusually potent transcriptional activator. Nature 335, 563-564
26. Yoneda, Y. (2000) Nucleocytoplasmic protein traffic and its significance to cell function. Genes Cells 5, 777-787
27. Gianni, D., Zambrano, N., Bimonte, M., Minopoli, G., Mercken, L., Talamo, F., Scaloni, A. and Russo, T. (2003) Platelet-derived growth factor induces the secretase-mediated cleavage of Alzheimer's amyloid precursor protein through a Src-Rac-dependent pathway. J. Biol. Chem. 278, 9290-9297
28. Su, H. P., Brugnera, E., Van Criekinge, W., Smits, E., Hengartner, M., Bogaert, T. and Ravichandran, K. S. (2000) Identification and characterization of a dimerization domain in CED-6, an adapter protein involved in engulfment of apoptotic cells. J. Biol. Chem. 275, 9542-9549
29. Shaw, G., Morse, S., Ararat, M. and Graham, F. L. (2002) Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J. 16, 869-871
30. Guttman, M., Betts, G. N., Barnes, H., Ghassemian, M., van der Geer, P. and Komives, E. A. (2009) Interactions of the NPXY microdomains of the low density lipoprotein receptor-related protein 1. Proteomics 9, 5016-5028
31. Cao, X. and Sudhof, T. C. (2004) Dissection of amyloid-precursor protein-dependent transcriptional transactivation. J. Biol. Chem. 279, 24601-24611
32. Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J. and Guenette, S. (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid protein, and the amyloid precursor protein intracellular domain in vivo. Proc. Natl. Acad. Sci. U.S.A. 100, 4162-4167
33. Edbauer, D., Willem, M., Lammich, S., Steiner, H. and Haass, C. (2002) Insulin-degrading enzyme rapidly removes the amyloid precursor protein intracellular domain (AICD). J. Biol. Chem. 277, 13389-13393
34. Duilio, A., Zambrano, N., Mogavero, A. R., Ammendola, R., Cimino, F. and Russo, T. (1991) A rat brain mRNA encoding a transcriptional activator homologous to the DNA binding domain of retroviral integrases. Nucleic Acids Res. 19, 5269-5274
35. Simeone, A., Duilio, A., Fiore, F., Acampora, D., De Felice, C., Faraonio, R., Paolocci, F., Cimino, F. and Russo, T. (1994) Expression of the neuron-specific FE65 gene marks the development of embryo ganglionic derivatives. Dev. Neurosci. 16, 53-60
36. Hebert, S. S., Serneels, L., Tolia, A., Craessaerts, K., Derks, C., Filippov, M. A., Muller, U. and De Strooper, B. (2006) Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes. EMBO Rep. 7, 739-745
37. Dormann, D., Rodde, R., Edbauer, D., Bentmann, E., Fischer, I., Hruscha, A., Than, M. E., Mackenzie, I. R., Capell, A., Schmid, B. et al. (2010) ALS-associated fused in sarcoma (FUS) mutations disrupt transportin-mediated nuclear import. EMBO J. 29, 2841-2857
38. Chu, C. T., Plowey, E. D., Wang, Y., Patel, V. and Jordan-Sciutto, K. L. (2007) Location, location, location: altered transcription factor trafficking in neurodegeneration. J. Neuropathol. Exp. Neurol. 66, 873-883
39. Su, B., Liu, H., Wang, X., Chen, S. G., Siedlak, S. L., Kondo, E., Choi, R., Takeda, A., Castellani, R. J., Perry, G. et al. (2009) Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease. Mol. Neurodegener. 4, 32